Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Neuroscience Letters

• Publication date

  2001-03-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0304-3940(01)01556-7PMID 11207383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The oligodendroglia cytoskeleton in health and disease

  2000cited by this paper
• Brain atrophy as a surrogate marker in MS

  2000cited by this paper
• Increased Cerebrospinal Fluid Tau Protein in Multiple Sclerosis

  2000cited by this paper
• Progressive cerebral atrophy in MS

  2000cited by this paper
• Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS

  1999cited by this paper
• A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy.

  1999cited by this paper
• Tau protein in cerebrospinal fluid: a new diagnostic and prognostic marker in Alzheimer disease?

  1998cited by this paper
• Intercellular adhesion molecule-1 in cerebrospinal fluid--the evaluation of blood-derived and brain-derived fractions in neurological diseases.

  1998cited by this paper
• β‐Trace protein in cerebrospinal fluid: A blood–CSF barrier–related evaluation in neurological diseases

  1998cited by this paper
• Soluble adhesion molecules (sVCAM‐1 and sICAM‐1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis

  1997cited by this paper
• Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

  1997cited by this paper
• Tau protein and apolipoprotein E in CSF diagnostics of Alzheimer's disease: impact on non Alzheimer's dementia?

  1996cited by this paper
• Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease

  1995cited by this paper
• The Filtration Concept of the Blood-CSF-Barrier as Basis for the Differentiation of CSF Proteins

  1995cited by this paper
• Increased cerebrospinal fluid tau in patients with Alzheimer's disease.

  1995cited by this paper
• New Concepts of a Blood—Brain Barrier

  1995cited by this paper
• Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases.

  1994cited by this paper
• Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration.

  1994cited by this paper
• Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay

  1993cited by this paper
• Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

  1993cited by this paper
• MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum

  1987cited by this paper
• The distribution of tau in the mammalian central nervous system

  1985cited by this paper

• The lifespan continuum of brain disorders: investigating links between neurodevelopmental and neurodegenerative disease-chicken or egg?

  2026cites this paper
• Neuroglial biomarkers in autoimmune encephalitis: advances in diagnosis, prognosis, and pathophysiological insights

  2025cites this paper
• A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach

  2024cites this paper
• Waste Clearance in the Brain and Neuroinflammation: A Novel Perspective on Biomarker and Drug Target Discovery in Alzheimer’s Disease

  2022cites this paper
• CSF Diagnostics: A Potentially Valuable Tool in Neurodegenerative and Inflammatory Disorders Involving Motor Neurons: A Review

  2021cites this paper
• Role of cerebrospinal fluid tau protein levels as a biomarker of brain injury in pediatric status epilepticus

  2021cites this paper
• The study of Tau and phospho Tau protein levels in attention deficit and hyperactivity disorder

  2021influential citation
• Plasma tau protein and Aβ42 level as markers of cognitive impairment in patients with Parkinson's disease.

  2020cites this paper
• High Diagnostic Accuracy of RT-QuIC Assay in a Prospective Study of Patients with Suspected sCJD

  2020cites this paper
• Targeting higher levels of lactate in the post-injury period following traumatic brain injury.

  2020cites this paper
• Enteroviral meningitis reduces CSF concentration of Aβ42, but does not affect markers of parenchymal damage

  2019cites this paper
• Targeting Higher Levels of Tau Protein in Ukrainian Patients with Wilson’s Disease

  2019cites this paper
• Assessment of the tau protein concentration in patients with tick-borne encephalitis

  2019cites this paper
• Neurofilament light chains in serum and cerebrospinal fl uid and status of blood-CSF bar rier in the selected neurological diseases

  2018cites this paper
• Amyloid beta and tau proteins in Alzheimer’s disease and Down syndrome

  2018cites this paper
• Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis

  2018cites this paper
• The cerebrospinal fluid and barriers - anatomic and physiologic considerations.

  2017cites this paper
• Effect of erythropoietin combined with hypothermia on serum tau protein levels and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy

  2017cites this paper
• Cerebrospinal fluid biomarkers of infantile congenital hydrocephalus

  2017cites this paper
• Science is 1% inspiration and 99% biomarkers

  2017cites this paper
• Title CSF tau protein is a useful marker for effective treatment of superficialsiderosis of the central nervous system : Two case reports

  2017cites this paper
• Cerebrospinal fluid findings in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies.

  2017cites this paper
• CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis

  2017cites this paper
• Vascular diseases and bleedings.

  2017cites this paper
• Kapitel 11 – Marker des Liquor cerebrospinalis und des Blutes im Überblick

  2015cites this paper
• Tau protein levels in the cerebrospinal fluid of the patients with multiple sclerosis in an attack period: Low levels of tau protein may have significance, too.

  2015cites this paper
• Physiology and Constituents of CSF

  2015cites this paper
• CSF Findings in Guillain-Barré Syndrome: Demyelinating and Axonal Acute Inflammatory Polyneuropathies

  2015cites this paper
• Acute encephalitis in childhood : clinical characteristics and outcome with special reference to tick-borne encephalitis

  2014cites this paper
• Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients

  2014cites this paper
• Markers of Prognosis in Neurodegenerative Dementia

  2014cites this paper
• Microfluidic Valves Made From Polymerized Polyethylene Glycol Diacrylate.

  2014cites this paper
• Institutet , Stockholm , Sweden ACUTE ENCEPHALITIS IN CHILDHOOD : Clinical Characteristics and Outcome-with Special Reference to Tick-Borne Encephalitis

  2014cites this paper
• The Cytoskeleton

  2013cites this paper
• Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain–Barré syndrome

  2013cites this paper
• Total Protein Level in Cerebrospinal Fluid is Stable in Elderly Adults

  2013cites this paper
• Neurofilaments: Properties, Functions, and Regulation

  2013cites this paper
• A case of sporadic Creutzfeldt – Jakob disease and discussion on diagnostic biomarkers

  2013cites this paper
• Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barresyndrome

  2013cites this paper
• MAPT gene rs1052553 variant is not associated with the risk for multiple sclerosis.

  2013cites this paper
• Molecular biomarkers of neurodegeneration

  2013cites this paper
• Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.

  2013cites this paper
• Tau protein: a possible prognostic factor in optic neuritis and multiple sclerosis

  2012cites this paper
• Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy

  2012cites this paper
• Avidity of anti-neurocytoskeletal antibodies in cerebrospinal fluid and serum

  2012cites this paper
• A case of anti-GA1 antibody-positive Fisher syndrome with elevated tau protein in cerebrospinal fluid.

  2012cites this paper
• Biochemical markers of autoimmune diseases of the nervous system.

  2012cites this paper
• Elevation of tau protein levels in the cerebrospinal fluid of children with West syndrome.

  2012cites this paper
• Cerebrospinal Fluid and Blood Biomarkers of Neuroaxonal Damage in Multiple Sclerosis

  2011cites this paper
• Cingulum fiber diffusivity and CSF T-tau in patients with subjective and mild cognitive impairment.

  2011cites this paper
• Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders

  2011cites this paper
• Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS

  2011cites this paper
• CSF and serum total-tau and phospho-tau(181P) in MS patients

  2011cites this paper
• Bacterial Contamination and the Transport Vial Material Affect Cerebrospinal Fluid Concentrations of β-Amyloid and Tau Protein as Determined by Enzyme Immunoassay

  2011cites this paper
• The Use of S100B and Tau Protein Concentrations in the Cerebrospinal Fluid for the Differential Diagnosis of Bacterial Meningitis: A Retrospective Analysis

  2011cites this paper
• Erratum

  2011cites this paper
• Biomarkers in Clinical Drug Development: Parallel Analysis of Alzheimer Disease and Multiple Sclerosis

  2010cites this paper
• Santral Sinir Sisteminin Dejeneratif Hastal ıklarında BOS Tau Düzeylerinin Bir Belirteç Olarak Kullan ımı : Bir Gözden Geçirme Yaz ı s ı

  2010cites this paper
• CSF glial markers correlate with survival in amyotrophic lateral sclerosis

  2010cites this paper
• Relationship between ALS and the degree of cognitive impairment, markers of neurodegeneration and predictors for poor outcome. A prospective study

  2010cites this paper
• Transactions of the Royal Society of Tropical Medicine and Hygiene

  2010cites this paper
• CSF tau protein is a useful marker for effective treatment of superficial siderosis of the central nervous system: two case reports.

  2010cites this paper
• Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity

  2010cites this paper
• Cerebral white matter changes : Differentiating vascular and degenerative cognitive impairment

  2009cites this paper
• Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis

  2009cites this paper
• Cerebrospinal fluid biomarkers in Guillain-Barré syndrome – Where do we stand?

  2009cites this paper
• Cerebrospinal fluid biomarkers in bacterial meningitis / Biomarker im Liquor cerebrospinalis bei bakterieller Meningitis

  2009cites this paper
• Cerebral white matter changes Differentiating vascular and degenerative cognitive impairment by Vidar

  2009cites this paper
• CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain‐Barré syndrome

  2009cites this paper
• Cerebrospinal fluid tau as a marker of neuronal damage after epileptic seizure.

  2009cites this paper
• Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluid.

  2008cites this paper
• Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

  2008cites this paper
• Blood and CSF biomarkers for investigation of the immunopathogenesis of relapse in Multiple Sclerosis

  2008cites this paper
• Biochemical markers in CSF of ALS patients.

  2008cites this paper
• Seizures in children with acute falciparum malaria : risk factors, mechanisms of neuronal damage and neuro-protection

  2008cites this paper
• Cerebrospinal fluid tau, phospho‐tau181 and β‐amyloid1−42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease

  2007cites this paper
• Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis

  2007cites this paper
• Axonal and astrocyte injury markers in the cerebrospinal fluid of Kenyan children with severe malaria.

  2007cites this paper
• CSF biomarkers for improved prognostic accuracy in acute CNS disease

  2007cites this paper
• Erythropoietin in Cerebrospinal Fluid: Age-related Reference Values and Relevance in Neurological Disease

  2007cites this paper
• CSF tau protein: A new prognostic marker for Guillain-Barré syndrome

  2006cites this paper
• Axonal damage markers in cerebrospinal fluid are increased in ALS

  2006cites this paper
• Docking studies of Tau Protein

  2006cites this paper
• Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis

  2006cites this paper
• C-Reactive protein and inflammatory response associated to neurocognitive decline following cardiac surgery.

  2006cites this paper
• QUANTIFICATION OF NEUROMETABOLITES IN SUBACUTE SCLEROSING PANENCEPHALITIS BY 1H-MRS

  2006cites this paper
• Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis

  2006cites this paper
• The Changes of Cytoskeletal Proteins in Plasma of Acrylamide-Induced Rats

  2006cites this paper
• The CSF levels of total-tau and phosphotau in patients with relapsing-remitting multiple sclerosis

  2006cites this paper
• Tau protein as a serum marker of brain damage in mild traumatic brain injury: Preliminary results

  2006cites this paper
• Kapitel 12 – Marker des Liquor cerebrospinalis und des Blutes im Überblick

  2006cites this paper
• Case records of the Massachusetts General Hospital. Case 22-2006--a 77-year-old man with a rapidly progressive gait disorder.

  2006cites this paper
• The Diagnostic Value of Cerebrospinal Fluid Tau Protein in Dementing and Nondementing Neuropsychiatric Disorders

  2005cites this paper
• Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis

  2005cites this paper
• Bases moleculares de la Neuroinmunologí a (I). Barrera sangre-lí quido cefalorraquí deo y sí ntesis intratecal de inmunoglobulinas

  2005cites this paper
• Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.

  2005cites this paper
• Cerebrospinal fluid levels of markers of brain parenchymal damage in Vietnamese adults with severe malaria.

  2005cites this paper
• Tau, Phospho-Tau, and S-100B in the Cerebrospinal Fluid of Children With Multiple Sclerosis

  2005cites this paper
• Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis

  2005cites this paper
• Inflammation and Neuroaxonal Injury in Multiple Sclerosis and AIDS Dementia Complex: Implications for Neuroprotective Treatment

  2005cites this paper